全文获取类型
收费全文 | 45308篇 |
免费 | 3470篇 |
国内免费 | 1949篇 |
专业分类
耳鼻咽喉 | 466篇 |
儿科学 | 547篇 |
妇产科学 | 497篇 |
基础医学 | 7838篇 |
口腔科学 | 906篇 |
临床医学 | 4154篇 |
内科学 | 6645篇 |
皮肤病学 | 332篇 |
神经病学 | 4655篇 |
特种医学 | 2282篇 |
外国民族医学 | 1篇 |
外科学 | 7030篇 |
综合类 | 5668篇 |
现状与发展 | 6篇 |
预防医学 | 1552篇 |
眼科学 | 896篇 |
药学 | 4134篇 |
9篇 | |
中国医学 | 1676篇 |
肿瘤学 | 1433篇 |
出版年
2024年 | 108篇 |
2023年 | 554篇 |
2022年 | 1229篇 |
2021年 | 1484篇 |
2020年 | 1388篇 |
2019年 | 1333篇 |
2018年 | 1466篇 |
2017年 | 1351篇 |
2016年 | 1242篇 |
2015年 | 1343篇 |
2014年 | 2450篇 |
2013年 | 2537篇 |
2012年 | 2364篇 |
2011年 | 2712篇 |
2010年 | 2285篇 |
2009年 | 2264篇 |
2008年 | 2357篇 |
2007年 | 2430篇 |
2006年 | 2140篇 |
2005年 | 1906篇 |
2004年 | 1663篇 |
2003年 | 1567篇 |
2002年 | 1326篇 |
2001年 | 1078篇 |
2000年 | 883篇 |
1999年 | 801篇 |
1998年 | 795篇 |
1997年 | 787篇 |
1996年 | 697篇 |
1995年 | 608篇 |
1994年 | 548篇 |
1993年 | 497篇 |
1992年 | 477篇 |
1991年 | 453篇 |
1990年 | 374篇 |
1989年 | 333篇 |
1988年 | 305篇 |
1987年 | 264篇 |
1986年 | 223篇 |
1985年 | 302篇 |
1984年 | 262篇 |
1983年 | 160篇 |
1982年 | 235篇 |
1981年 | 211篇 |
1980年 | 179篇 |
1979年 | 148篇 |
1978年 | 139篇 |
1977年 | 130篇 |
1976年 | 126篇 |
1975年 | 55篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Tetsuo Shoji Yoshiki Nishizawa 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2006,10(Z1):S27-S33
Abstract: The risk of cardiovascular death is high in hemodialysis (HD) patients, and thickening, stiffening and calcification of the arterial wall have been shown as its predictive factors. Activated vitamin D preparations are used for the treatment of secondary hyperparathyroidism in HD patients, but as they increase serum phosphate and calcium concentrations, there is a concern that they promote vascular calcification and, consequently, exacerbate the outcomes. In this article, the effects of vitamin D therapy on survival, cardiac function, arteriosclerosis, immunity, and inflammation are evaluated by reviewing the literature. In HD patients, the risk of death (particularly cardiovascular death) is significantly lower in those treated than in those not treated with vitamin D. Moreover, activated vitamin D improves cardiac function and alleviates cardiac hypertrophy in HD patients. Experimental data in cultured macrophages, vascular smooth muscle cells, and vascular endothelial cells suggest that it has antiatherosclerotic effects. In vivo, the administration of vitamin D improves immune functions and normalizes inflammatory reactions. In HD patients, vascular calcification is related to the dose of calcium carbonate, but its relationship with the administration of vitamin D is not significant. These observations suggest that, contrary to the general concerns, activated vitamin D exerts favorable effects on the cardiovascular system in HD patients as long as it is used in appropriate clinical doses. 相似文献
42.
Spinal cord stimulation (SCS) is widely used for pain relief in patients with failed back surgery syndrome (FBSS), and muscle weakness is a common finding in patients with chronic pain. We present here a single case report of a 47‐year‐old woman, who, after SCS for FBSS, had continuous improvement in lower leg muscle strength and gait, but only transient and minimal pain relief. To the authors’ knowledge, this is only the second published case report of significant improvement in “motor” function, independent of the analgesic effect following SCS in FBSS. If SCS, in fact, does improve muscle strength, new strategies for the management of patients with chronic pain might be opened up. Further studies are needed to verify this hypothesis. 相似文献
43.
目的研究血管内皮生长因子(VEGF)在膀胱移行细胞癌(TCC)中的表达。方法应用免疫组织化学染色方法观察62例TCC标本VEGF的表达情况。结果TCC组中VEGF的阳性表达率为56.5%(35,62),而8例正常膀胱粘膜组织VEGF表达均为阴性,两组比较差异有高度显著性p〈0.01(x^2=9.032);VEGF表达与膀胱肿瘤病理分级、临床分期、复发密切相关。结论VEGF的异常表达在TCC的发生、发展过两组比较差异有程中起重要作用;该指标的检测有助于预后判断。 相似文献
44.
45.
目的分析体外培养的骨髓单个核细胞持续分泌促血管生长因子的能力。方法从大鼠胫骨及股骨采集骨髓,密度梯度离心法分离出骨髓单个核细胞进行体外培养,并连续收集4周培养上清液。酶联免疫吸附实验(ELISA)法测定培养上清液中碱性成纤维细胞生长因子(bFGF)、血管内皮细胞生长因子(VEGF)和白介素-1β(IL-1β)等因子水平。结果第1、2、3、4周骨髓单个核细胞体外培养上清液中VEGF分别为(24.40±7.99)pg/m、l(89.28±5.13)pg/m、l(115.24±10.08)pg/m、l(157.00±15.64)pg/m l;bFGF含量分别为(52.72±2.13)pg/m、l(48.10±6.41)pg/m、l(44.71±3.21)pg/m、l(25.61±2.42)pg/m l;IL-1β含量分别为:(31.28±5.44)pg/m、l(71.87±3.01)pg/m、l(55.77±11.94)pg/m、l(41.75±9.14)pg/m。l结论体外培养骨髓单个核细胞可持续分泌VEGF、bFGF、IL-1β等多种促血管生长因子。 相似文献
46.
A. Esquenazi 《European journal of neurology》2006,13(S4):27-34
Spasticity is a widespread, disabling form of muscle overactivity affecting patients with central nervous system damage resulting in upper motor neurone syndrome. There is a range of effective therapies for the treatment of spasticity (e.g. physical, anaesthetic, chemodenervation and neurolytic injections, systemic medication and surgery), but all therapies must be based on an individualized, multidisciplinary programme targeted to achieve patient goals. Appropriate therapy should be based on the extent and severity of spasticity, but spasticity and its consequences, regardless of presentation or cause, are commonly treated with systemic agents. This may be ill-advised as systemic treatment is associated with many undesirable effects. In particular, elderly patients with post-stroke spasticity are at risk from the central adverse effects of systemic medication (e.g. sedation and gait disturbance), which make them more susceptible to falling, with an associated increased risk of fracture. The rising costs of fracture care and its sequelae are fast becoming an international problem contributing to high healthcare expenditure. Botulinum toxin type-A (BoNT-A) treatment is highly effective for some of the more common forms of spasticity and muscle overactivity, and has a favourable profile when compared with systemic agents and other focal treatments. Therefore, the clinical benefits of BoNT-A treatment outweigh the apparent high costs of this intervention, showing it to be a cost-effective treatment. 相似文献
47.
前循环缺血性卒中老年患者颈动脉斑块及其稳定性与血流壁切应力的关系 总被引:5,自引:2,他引:3
目的通过探讨前循环缺血性卒中老年患者颈总动脉分叉处血流壁切应力的水平分析其在颈动脉斑块形成过程中的影响。方法本研究选择前循环缺血性卒中老年患者,应用经皮血管彩超测量颈动脉斑块及其稳定性以及对研究对象测量患侧颈动脉血流速度、血管内径和血液粘滞度,通过公式计算血流壁切应力。结果无斑块组和有斑块组之间、高回声和低回声斑块组之间血流壁切应力均有显著性差异(P<0.01)。结论血流壁低切应力促进颈动脉斑块、尤其是不稳定斑块的形成。 相似文献
48.
血管内皮生长因子及炎性因子在油酸性犬急性呼吸窘迫综合征中的变化 总被引:1,自引:0,他引:1
目的探讨油酸性急性呼吸窘迫综合征(ARDS)beagle犬血浆及肺泡灌洗液血管内皮生长因子(VEGF)、可溶性细胞间黏附分子-1(ICAM-1)、白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF—α)水平的改变。方法12只英国纯种beagle犬,静脉注射油酸0.15mL/kg,在注射油酸前、后1h,出现ARDS的典型表现时,抽血测VEGF、sICAM-1、IL-8、TNF—α,并对此时相作肺泡灌洗液VEGF、sICAM—1、IL-8、TNF-α的测定。结果beagle犬静脉注射油酸后1h血浆TNF—α升高(P〈0.05),血浆反肺泡灌洗液IL8、sICAM-1和VEGF在1h较油酸前没有明显变化(P〉0.05),beagle犬油酸型ARDS模型建立后血浆及肺泡灌洗液VECF、sICAM-1、IL-8、TNF—α均显著高于建模前(P〈0.05)。结论VEGF、sICAM-1、IL-8、TNF~α在beagle犬油酸型ARDS发生发展过程中可能均起重要作用,其水平的高低可能与ARDS严重程度及预后有关。 相似文献
49.
Vascular malformation (AVM) in the gastrointestinal tract is an uncommon, but not rare, cause of bleeding and iron deficiency anemia, especially in an aging population. While endoscopic coagulative therapy is the method of choice for controlling bleeding, a substantial number of cases require additional therapy. Adjunctive or even primary phamacotherapy may be indicated in recurrent bleeding. However, there is little evidence-based proof of efficacy for any agent. The bulk of support is derived from anecdotal reports or case series. The present review compares the outcome of AVM after no intervention, coagulative therapy or focus on pharmacological agents. Most of the literature encompasses two common AVMs, angiodysplasia and hereditary hemorrhagic telangiectasia. Similarly, the bulk of information evaluates two therapies, hormones (estrogen and progesterone) and the somatostatin analogue octreotide. Of these, the former is the only therapy evaluated in randomized trials, and the results are conflicting without clear guidelines. The latter therapy has been reported only as case reports and case series without prospective trials. In addition, other anecdotally used medications are discussed. 相似文献
50.
分子靶向药物bevacizumab是针对血管内皮生长因子(VEGF)的重组人源化单克隆抗体,在多种恶性肿瘤的治疗中显示了临床效果。现就bevacizumab的作用机制及其在乳腺癌治疗中的临床研究进展作一综述。 相似文献